APO AB 300 (Abacavir sulfate 300 mg (base))

Pill imprint APO AB 300 has been identified as Abacavir sulfate 300 mg (base).

Abacavir is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Abacavir 300 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Abacavir sulfate

Imprint:

APO AB 300

Strength:

300 mg (base)

Color:

Yellow

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Nucleoside reverse transcriptase inhibitors (NRTIs)

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Apotex Corp

National Drug Code (NDC):

60505-3583

Inactive Ingredients:

silicon dioxide colloidal
magnesium stearate
microcrystalline cellulose
hypromelloses
polyethylene glycol 8000
ferric oxide yellow
croscarmellose sodium
titanium dioxide

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
00904-6523	Major Pharmaceuticals

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.